ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
66.931,62
-0,01%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cynapsus Therapeutics Inc. (MM) (CYNA)

  7. Cynapsus Therapeutics Inc. (MM) (CYNA) News

CYNA

Cynapsus Therapeutics Inc. (CYNA)

Cynapsus Therapeutics Inc. (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CYNA
DatumZeitQuelleÜberschriftSymbolFirma
04/05/202214h05Business WireCyngn Launches Infinitracker – A GPS Asset Tracker and IoT Gateway with 15-year BatteryNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
02/05/202214h05Business WireCyngn Schedules 2022 First Quarter Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
29/04/202222h20Business WireCyngn Announces Closing of $20 Million Private Placement Priced At-the-MarketNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
28/04/202215h15Business WireCyngn Announces Pricing of $20 Million Private Placement Priced At-the-MarketNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/04/202214h30Business WireCyngn Launches DriveMod Kit, a Fully-Equipped Autonomous Vehicle Hardware Integration ModuleNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
23/03/202221h05Business WireCyngn Reports Fourth Quarter and Year-end 2021 ResultsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
14/03/202213h05Business WireCyngn Schedules 2021 Fourth Quarter and Year-End Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
23/02/202214h05Business WireCyngn to Present at the Cowen 2nd Annual Mobility Disruption ConferenceNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
15/02/202214h05Business WireCyngn Files Patent for DriveMod Kit, an Adaptive, Turnkey Autonomous Vehicle SolutionNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
10/02/202214h05Business WireCyngn to Present at the Aegis Virtual ConferenceNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
03/02/202214h00Business WireGreenland Technologies Chooses Cyngn to Bring Autonomous Vehicle Technology to Their Fleet of Lithium-Powered Electric ForkliftsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
24/01/202214h05Business WireCyngn Announces Appointment of HR Veteran Marc Brown as Vice President of Human ResourcesNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
18/01/202214h05Business Wire Cyngn and Columbia Vehicle Group to Begin Building Fleet of Autonomous Industrial VehiclesNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
10/01/202214h05Business WireGlobal Logistics & Fulfillment Taps Cyngn to Bring Autonomous Vehicle Capabilities to its Fulfillment CentersNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
08/12/202114h05Business WireCyngn to Provide an Insider’s Look into the Company’s Technology Stack in its First Webinar on December 15, 2021NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
17/11/202122h05Business WireCyngn Reports Third Quarter 2021 ResultsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
09/11/202114h30Business WireCyngn Schedules 2021 Third Quarter Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
22/10/202118h10Business WireCyngn Announces Closing of Initial Public OfferingNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
19/10/202123h31Business WireCyngn Announces Pricing of Initial Public OfferingNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
17/03/202021h23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
15/02/201713h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
03/02/201722h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
08/12/201623h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
01/11/201618h25Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
24/10/201623h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201623h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201623h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201623h14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201615h22Edgar (US Regulatory)(25-NSE)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
18/10/201619h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:CYNA

Kürzlich von Ihnen besucht

TSXV
TRB.H
Tribute Resources
AMEX
JOL
Joule
ASX
BOM
Bondi Mining
ASX
QBEBOR
COIN
RC20EUR
BIT
1CMCSA
Comcast
COIN
XGMUSD
EU
RCFAE
Teleperformance SE Med T...
UNSW3
WOZXETH
EFFORCE IEO
POLO
DMGBTC
DMM: Governance
USOTC
DSTRF
DevvStream (QB)
BOV
A1EP34M
American Electric Power
BIT
F18138
Vontobel Financial Produ...
LSE
BLO
COIN
OKSUST
Oikos Network Token
BITMOT
844359
Siemens Fin Tf 1,75% Fb3...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten